Potent antimicrobial peptide against Gram-negative (MIC=0.25 ug/ml against E.coli ATCC 25922, MIC=0.5 ug/ml against P.aeruginosa) and Gram-positive bacteria (MIC=64 ug/ml against E.faecalis, MIC=64 ug/ml against S.aureus) (PubMed:25100358). Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane (By similarity). Low hemolytic activities have been observed on mammalian cells (PubMed:25100358). Forms a helical membrane channel in the prey. Expressed by the venom gland. The peptide length (30 residues) shown here is propagated from the directly sequenced mature cathelicidin-BF. A longer peptide (34 residues) with predicted cleavage site located at position Val-157-158-Lys is proposed in PubMed:18620012. This 30 residues peptide could result from a further processing. The putative mature sequence has been predicted by AMPA, a predictive algorithm for identification of peptide stretches with antimicrobial properties. Belongs to the cathelicidin family.